Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$44.33 - $57.82 $6,028 - $7,863
-136 Reduced 83.44%
27 $2,000
Q4 2021

Feb 10, 2022

BUY
$40.27 - $56.99 $6,564 - $9,289
163 New
163 $7,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Sageworth Trust CO Of South Dakota Portfolio

Follow Sageworth Trust CO Of South Dakota and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO Of South Dakota, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO Of South Dakota with notifications on news.